Expert Details
Radiology, Nuclear Medicine, Nuclear Pharmacy, Molecular Imaging, Patient Safety, Compounding
ID: 731800
North Carolina, USA
Expert is highly experienced regarding supply chains for radiopharmaceuticals, contrast agents and drugs used in radiology. His research interests focus on the development of theranostic radiopharmaceuticals, which include Gallium-68 radiolabeled peptides for diagnostic imaging and Ytterium-90 and Lutetium-177 radiolabeled peptides for therapy of neuroendocrine tumors and other cancers.
Expert is a highly recognized expert in radiopharmacy, also commonly referred to as nuclear pharmacy. He has been a board certified nuclear pharmacist (BCNP) in good standing for nearly 30 years. Radiopharmacy is the branch of pharmacy concerned with procurement, compounding, quality control and dispensing of radiopharmaceuticals (radioactive drugs) intended for use in diagnostic imaging procedures and for use in therapeutic procedures. Diagnostic procedures include single photon emission tomography (SPECT) and positron emission tomography (PET) imaging. Therapeutic procedures include those for thyroid cancer, neuroendocrine tumors, liver tumors, metastatic bone cancer, brain tumors and others.
Nuclear Pharmacy (Radiopharmacy) ConsultantConsultant Assisted preparation and submission of a New Drug Application (NDA) for I-131 meta-iodobenzylguanidine (MIBG) a diagnostic adjunct in the diagnosis of pheochromocytoma and neuroblastoma.Nuclear Pharmacy Consultant, Clinical Pharmacists/Study Coordinator; management of clinical trials conducted at the University of Michigan leading to NDA approval of Adenoscan™ (adenosine) as a pharmacological adjunct in myocardial perfusion imaging.Nuclear Pharmacy Consultant, Member, Radioactive Drug Research Committee (RDRC).Nuclear Pharmacy Consultant, Consultant charged with providing comprehensive services to facilitate the clinical and research use of SPECT and PET radiopharmaceuticals for molecular imaging and therapy in pediatric populations.
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1975 | Degree: BS, | Subject: Pharmacy | Institution: Prudue University |
| Year: 1977 | Degree: MS | Subject: Bionucleonics - Nuclear Pharmacy | Institution: Purdue University |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 1998 to Present | Employer: Undisclosed | Title: Associate Professor of Radiology; Director, Radiopharmacy Services | Department: Radiology / Nuclear Medicine |
Responsibilities:Expert is directly responsible for the procurement, compounding, quality control, dispensing and safe use of all diagnostic and therapeutic radiopharmaceuticals employed in research and clinical settings. He also plays a major role in overall institutional compliance within radiology as member of various drug use and safety committees. Expert has knowledge and experience regarding the regulations and pharmacy practice standard governing the safe compounding of drugs and medications for patient care. |
|||
| Years | Employer | Title | Department |
| Years: 1983 to 1998 | Employer: University of Michigan Medical Center | Title: Director, Radiopharmacy Services | Department: Radiology / Nuclear Medicine |
Responsibilities:Expert was directly responsible for the procurement, compounding, quality control, dispensing and safe use of all diagnostic and therapeutic radiopharmaceuticals employed in research and clinical settings. He also played a major role in overall institutional compliance within radiology as member of various drug use and safety committees. |
|||
Additional Experience
| Expert Witness Experience |
|---|
| He has served as an expert witness, given depositions, reviewed depositions and provided pre-trial consultation to defense law firms in state level courts. He has done some of this work as an expert consultant for the North Carolina Board of Pharmacy. |
Career Accomplishments
| Associations / Societies |
|---|
| MEMBERSHIPS: American Pharmacists Association (APhA) American Society of Health-System Pharmacists (ASHP) Society of Nuclear Medicine and Molecular Imaging (SNMMI) North Carolina Association of Pharmacists (NCAP) |
| Licenses / Certifications |
|---|
| CURRENT PHARMACY LICENSURE: North Carolina, Reinstated SPECIALITY CERTIFICATION: Board Certified Nuclear Pharmacist: Certified: Re-Certified Authorized Nuclear Pharmacist (ANP) University of Michigan Medical Center Employer |
| Awards / Recognition |
|---|
| PROFESSIONAL AWARDS AND SPECIAL RECOGNITION: Rho Chi Society (Pharmacy Honorary), Fellow of the American Pharmacists Association (FAPhA), Distinguished Achievement Award, Division of Nuclear Medicine, University of Michigan, Fellow – Leonard Davis Institute of Health Economics, The Wharton School, University of Pennsylvania, GlaxoSmithKline Executive Management Program for Pharmacy Leaders, Philadelphia, PA. William H. Briner Distinguished Achievement Award in Nuclear Pharmacy Practice, Academy of Pharmacy Practice and Management, American Pharmacists Association. |
| Publications and Patents Summary |
|---|
| He has 54 publications and 7 book chapters. |